Summary of the clinical practice guideline for the treatment of depression across three age cohorts
Bibliographic Data
| ID | 8713952 |
|---|---|
| Authors | Guideline Development Panel for the Treatment of Depressive Disorders (corresponding author) |
| Year | 2021 |
| Volume | 77 |
| Issue | 6 |
| Pages | 770-780 |
| Publication date | 2021-11-29 |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Psychologist (JOURNAL) |
| Journal identifiers | ISSN: 0003-066X • E-ISSN: 1935-990X |
| Publisher | American Psychological Association (PUBLISHER • US) |
| DOI | 10.1037/amp0000904 |
| PMID | 34843274 |
| OpenAlex | W4200504106 |
| Language | EN |
| Citations received | 13 |
The American Psychological Association (APA) developed this clinical practice guideline to provide recommendations for the treatment of depressive disorders, including major depression, subsyndromal depression, and persistent depressive disorder. It addresses three developmental cohorts: adolescents, general adults, and older adults (ages 60 and over). Ten systematic reviews and meta-analyses, along with other literature and observations from practitioners and patients, served as the basis for the guideline. The guideline development panel consisted of health professionals from psychology, psychiatry, and family medicine as well as community members who self-identified as having had depression. The panel examined the efficacy of psychological treatments and of complementary and alternative medicine treatments. It also examined comparative effectiveness among psychological treatments, by themselves and in combination with pharmacotherapy, and comparative effectiveness of psychological treatments in relation to pharmacotherapy and to complementary and alternative treatments. The panel made recommendations for treatment of depression in adolescents, adults, and older adults but did not make treatment recommendations specific to children. These recommendations, presented in detail in the guideline, are summarized here. The target audience for the guideline includes clinicians, researchers, patients, family members, and policymakers. (PsycInfo Database Record (c) 2022 APA, all rights reserved)
Depression (economics · Family medicine · Guideline · MEDLINE · Mental health · Pharmacotherapy · Psychiatry · PsycINFO · Childhood Cancer Survivors' Quality of Life · Medicine · Psychology · Clinical Psychology
Intergroup relations affect depressive symptoms of Indigenous people
Knowledge, attitudes, and practices among medical students toward depression management
Enhancing the psychological well-being and sleep quality of healthcare providers with a multimodal psychological support program
For Girls Only? Conditioning the Mediated Relationship between Depression, Cognitive Impulsivity, and Delinquency on Sex
Commentary
Effects of exercise on depression and anxiety in university students
The use of artificial intelligence in psychotherapy
Development and validation evaluation of the depressive disorders self-management scale for adolescents
Trends in prescription therapy for adolescents with depression in nine major areas of China during 2017–2021
The association of the triglyceride-glucose index and its changes with 5-year all-cause mortality in patients with depression
Prevalence of depressive symptoms and knowledge, attitude, and practice among adolescents in Chengdu, China
Resting-state fMRI graph theory analysis for predicting selective serotonin reuptake inhibitors treatment response in adolescent major depressive disorder
Research agenda evaluating measurement-based care for opioid use disorder among patients with co-occurring depressive disorders
| Citations per year | 4.33 |
|---|---|
| Citation span | 2023 - 2026 (4) |
| Highly cited | No |